1
Clinical Trials associated with HCP-2201A Randomized, Open Label, Single Dose, 4-period Replicate Crossover Clinical Trial to Evaluate the Pharmacokinetic Characteristics and Safety After Administration of a Fixed-dose Combination Drug of HCP2201 and Co-administration of RLD2205 and RLD2206 in Healthy Male Volunteers Under Fasting Conditions
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP2201 and co-administration of each component in fasting condition in healthy male volunteers.
100 Clinical Results associated with HCP-2201
100 Translational Medicine associated with HCP-2201
100 Patents (Medical) associated with HCP-2201
100 Deals associated with HCP-2201